Total Payments
$5,178
2024 Payments
$0
Companies
10
Transactions
88
Medicare Patients
3,117
Medicare Billing
$204,412
Payment Breakdown by Category
Consulting$2,720 (52.5%)
Travel$1,309 (25.3%)
Food & Beverage$977.61 (18.9%)
Education$171.64 (3.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,720 | 1 | 52.5% |
| Travel and Lodging | $1,309 | 5 | 25.3% |
| Food and Beverage | $977.61 | 69 | 18.9% |
| Education | $171.64 | 4 | 3.3% |
| Unspecified | $0 | 9 | 0.0% |
Payments by Type
General
$5,178
79 transactions
Ownership
$0
9 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NeoTract Inc. | $4,045 | 7 | $0 (2018) |
| Janssen Biotech, Inc. | $762.38 | 58 | $0 (2020) |
| Astellas Pharma US Inc | $164.00 | 2 | $0 (2022) |
| UroGPO LLC | $56.62 | 6 | $0 (2020) |
| Amgen Inc. | $44.36 | 3 | $0 (2017) |
| Cure Medical LLC | $43.23 | 1 | $0 (2021) |
| PFIZER INC. | $36.30 | 3 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $18.22 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $0 | 2 | SN Holdings, LLC |
| 2023 | $0 | 1 | SN Holdings, LLC |
| 2022 | $65.00 | 2 | Astellas Pharma US Inc ($65.00) |
| 2021 | $47.05 | 3 | Cure Medical LLC ($43.23) |
| 2020 | $48.52 | 5 | Janssen Biotech, Inc. ($26.48) |
| 2019 | $245.88 | 21 | Janssen Biotech, Inc. ($245.88) |
| 2018 | $4,433 | 34 | NeoTract Inc. ($4,029) |
| 2017 | $339.15 | 20 | Janssen Biotech, Inc. ($179.29) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2024 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 2023 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 11/04/2022 | Astellas Pharma US Inc | — | Education | In-kind items and services | $65.00 | General |
| 2022 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 03/26/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 02/25/2021 | Cure Medical LLC | Cure Catheter (Device) | Food and Beverage | Cash or cash equivalent | $43.23 | General |
| Category: Urology | ||||||
| 2021 | SN Holdings, LLC | — | — | — | $0.00 | Ownership |
| 04/17/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 03/06/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 02/24/2020 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Oncology | ||||||
| 02/11/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: ONCOLOGY | ||||||
| 2020 | UroGPO LLC | — | — | — | $0.00 | Ownership |
| 12/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 12/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Oncology | ||||||
| 11/15/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 11/15/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: Oncology | ||||||
| 11/06/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $6.30 | General |
| Category: Oncology | ||||||
| 10/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 10/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Oncology | ||||||
| 09/14/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Oncology | ||||||
| 09/14/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $5.91 | General |
| Category: Oncology | ||||||
| 08/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Oncology | ||||||
| 08/13/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Oncology | ||||||
| 07/10/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 574 | 2,130 | $241,556 | $38,317 |
| 2022 | 18 | 849 | 3,539 | $307,094 | $48,460 |
| 2021 | 20 | 854 | 3,782 | $350,767 | $58,640 |
| 2020 | 21 | 840 | 3,535 | $388,540 | $58,994 |
Total Patients
3,117
Total Services
12,986
Medicare Billing
$204,412
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 154 | $58,520 | $14,094 | 24.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 82 | 108 | $74,724 | $6,401 | 8.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 70 | 82 | $22,140 | $4,620 | 20.9% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 29 | 56 | $12,209 | $1,819 | 14.9% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 11 | 11 | $10,685 | $1,799 | 16.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $6,890 | $1,799 | 26.1% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 17 | $17,498 | $1,724 | 9.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $7,636 | $1,358 | 17.8% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 15 | 16 | $6,230 | $1,330 | 21.3% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 16 | 16 | $13,311 | $1,322 | 9.9% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 20 | 31 | $2,261 | $587.76 | 26.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 67 | 77 | $4,697 | $541.20 | 11.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 16 | 16 | $1,808 | $401.44 | 22.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 86 | 102 | $1,530 | $344.41 | 22.5% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 16 | 1,417 | $1,417 | $176.97 | 12.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 154 | $56,795 | $12,862 | 22.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 130 | $33,660 | $7,265 | 21.6% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 83 | 108 | $72,036 | $5,839 | 8.1% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2022 | 22 | 22 | $21,230 | $3,720 | 17.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $18,690 | $3,468 | 18.6% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2022 | 31 | 46 | $17,710 | $3,289 | 18.6% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2022 | 29 | 51 | $11,377 | $2,340 | 20.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2022 | 16 | 22 | $30,208 | $1,993 | 6.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 25 | 25 | $8,775 | $1,681 | 19.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $5,620 | $1,525 | 27.1% |
About David Esrig
David Esrig is a Urology healthcare provider based in Springfield, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306956065.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Esrig has received a total of $5,178 in payments from pharmaceutical and medical device companies, with $0 received in 2024. These payments were reported across 88 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($2,720).
As a Medicare-enrolled provider, Esrig has provided services to 3,117 Medicare beneficiaries, totaling 12,986 services with total Medicare billing of $204,412. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Springfield, OR
- Active Since 08/30/2006
- Last Updated 09/28/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1306956065
Products in Payments
- UROLIFT (Device) $3,036
- UroLift (Device) $992.47
- Erleada (Drug) $527.28
- ZYTIGA (Drug) $208.62
- Prolia (Biological) $44.36
- Cure Catheter (Device) $43.23
- SUTENT (Drug) $36.30
- ERLEADA (Drug) $26.48
- KEYTRUDA (Biological) $18.22
- Urolift - UL400 (Device) $16.50
- (815) Thiola (Drug) $3.82
- Thiola (Drug) $3.82
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Springfield
Bryan Mehlhaff, Md, MD
Urology — Payments: $1.5M
Urology $1.5M
Kevin Mcvary, Md, MD
Urology — Payments: $405,504
Urology $405,504
Bradley Schwartz, M.d, M.D
Urology — Payments: $105,537
Urology $105,537
Robert Nadler, Md, MD
Urology — Payments: $93,691
Urology $93,691
Kevin Krughoff
Urology — Payments: $54,104
Urology $54,104
Dr. Eric Espinosa
Urology — Payments: $23,023
Urology $23,023